Stay updated with breaking news from Medication Guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(BPT) - For those living with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) — known collectively as psoriatic disease[1] — every day can feel like a challenge. From PsO
(BPT) - For those living with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) — known collectively as psoriatic disease[1] — every day can feel like a challenge. From PsO
KEYNOTE-564 is the first Phase 3 trial to demonstrate superior overall survival with adjuvant therapy compared to placebo in patients with RCC Late-breaking OS results selected for the official...
